Analysis of the efficacy of avatrombopag for the delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation for aplastic anemia
For patients identified as being at high risk for poor platelet engraftment following allo-HSCT, early transition to AVA can significantly reduce the duration of DPE and promote platelet recovery post-transplantation. This strategy has the potential to enhance patient survival rates and overall outcomes.
Authors
- Yusheng Zhao (ORCID: https://orcid.org/0000-0003-1640-5216)
- Jia Feng (ORCID: https://orcid.org/0000-0003-1437-7813)
- Dijiong Wu
- Zhengsong Yan
- Baodong Ye (ORCID: https://orcid.org/0000-0001-5912-2633)
- Tonglin Hu
- Herui Zhang (ORCID: https://orcid.org/0000-0002-2719-2626)
- Huijin Hu
- Wenbin Liu (ORCID: https://orcid.org/0000-0002-9080-8040)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-1025-906X)
- Xinhe Zhang (ORCID: https://orcid.org/0000-0002-4325-6079)
- Liqiang Wu (ORCID: https://orcid.org/0000-0002-0463-3521)
- Zhengwei Tan
Institutions
- Zhejiang Chinese Medical University (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-08
- DOI
- https://doi.org/10.3389/fmed.2025.1626325
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00